Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists
| Parent link: | Medicinal Research Reviews Vol. 36, iss. 5.— 2016.— [P. 871-923] |
|---|---|
| Corporate Author: | |
| Other Authors: | , , , , , , , |
| Summary: | Title screen It has now been demonstrated that the µ, δ 1, δ 2, and K 1 opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis of cardiomyocytes during I/R and improve cardiac contractility in the reperfusion period. The OR agonists exert an infarct-reducing effect with prophylactic administration and prevent reperfusion-induced cardiomyocyte death when ischemic injury of heart has already occurred; that is, opioids can mimic preconditioning and postconditioning phenomena. Furthermore, opioids are also effective in preventing ischemia-induced arrhythmias. Режим доступа: по договору с организацией-держателем ресурса |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1002/med.21395 |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=652384 |